Conditional mineralocorticoid receptor expression in the heart leads to life-threatening arrhythmias

被引:226
|
作者
Ouvrard-Pascaud, A
Sainte-Marie, Y
Bénitah, JP
Perrier, R
Soukaseum, C
Cat, AND
Royer, A
Le Quang, K
Charpentier, F
Demolombe, S
Mechta-Grigoriou, F
Beggah, AT
Maison-Blanche, P
Oblin, ME
Delcayre, C
Fishman, GI
Farman, N
Escoubet, B
Jaisser, F
机构
[1] Coll France, INSERM, AVENIR, IFR 52, F-75231 Paris, France
[2] INSERM, U637, Montpellier, France
[3] INSERM, U533, Sch Med, Nantes, France
[4] Inst Pasteur, Unit Gene Express & Dis, Dept Dev Biol, Paris, France
[5] Univ Paris 07, AP HP,Hosp Bichat, INSERM, U426,CEFU,IFR02, Paris, France
[6] Univ Paris 07, AP HP,Hosp Bichat, INSERM, U478, Paris, France
[7] X Bichat Med Sch, Paris, France
[8] Hop Lariboisiere, INSERM, U572, F-75475 Paris, France
[9] NYU, Sch Med, Leon H Charney Div Cardiol, New York, NY USA
关键词
aldosterone; arrhythmia; hormones; ion channels; mineralocorticoid receptors;
D O I
10.1161/CIRCULATIONAHA.104.503706
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background - Life-threatening cardiac arrhythmia is a major source of mortality worldwide. Besides rare inherited monogenic diseases such as long-QT or Brugada syndromes, which reflect abnormalities in ion fluxes across cardiac ion channels as a final common pathway, arrhythmias are most frequently acquired and associated with heart disease. The mineralocorticoid hormone aldosterone is an important contributor to morbidity and mortality in heart failure, but its mechanisms of action are incompletely understood. Methods and Results - To specifically assess the role of the mineralocorticoid receptor (MR) in the heart, in the absence of changes in aldosteronemia, we generated a transgenic mouse model with conditional cardiac-specific overexpression of the human MR. Mice exhibit a high rate of death prevented by spironolactone, an MR antagonist used in human therapy. Cardiac MR overexpression led to ion channel remodeling, resulting in prolonged ventricular repolarization at both the cellular and integrated levels and in severe ventricular arrhythmias. Conclusions - Our results indicate that cardiac MR triggers cardiac arrhythmias, suggesting novel opportunities for prevention of arrhythmia-related sudden death.
引用
收藏
页码:3025 / 3033
页数:9
相关论文
共 50 条
  • [1] LIFE-THREATENING ARRHYTHMIAS
    ZONERAICH, S
    ZONERAICH, O
    MEDICAL CLINICS OF NORTH AMERICA, 1973, 57 (06) : 1503 - 1514
  • [2] Life-threatening Arrhythmias in Adults with Congenital Heart Diseased
    Oechslin, E.
    AKTUELLE KARDIOLOGIE, 2014, 3 (04) : 252 - 258
  • [3] Life-threatening arrhythmias and therapy
    Myerburg, RJ
    RESUSCITATION, 2000, 45 (03) : S1 - S2
  • [4] CONVERTING LIFE-THREATENING ARRHYTHMIAS
    SILVERMAN, ME
    CARDIOVASCULAR MEDICINE, 1985, 10 (03): : 53 - &
  • [5] TREATMENT OF LIFE-THREATENING ARRHYTHMIAS
    WALDO, AL
    ARCINIEGAS, JG
    PLUMB, VJ
    ALABAMA JOURNAL OF MEDICAL SCIENCES, 1981, 18 (03): : 262 - 268
  • [6] In hospital life-threatening arrhythmias
    Trappe, H. -J.
    NOTFALL & RETTUNGSMEDIZIN, 2011, 14 (02): : 109 - 116
  • [7] LIFE-THREATENING ARRHYTHMIAS AND INTRAVENOUS CIMETIDINE
    COHEN, J
    WEETMAN, AP
    DARGIE, HJ
    KRIKLER, DM
    BRITISH MEDICAL JOURNAL, 1979, 2 (6193): : 768 - 768
  • [8] SOTALOL MARKETED FOR LIFE-THREATENING ARRHYTHMIAS
    不详
    CLINICAL PHARMACY, 1993, 12 (03): : 176 - 176
  • [9] LIFE-THREATENING VENTRICULAR ARRHYTHMIAS IN SEPTICEMIA
    ADERKA, D
    SCLAROVSKY, S
    LEWIN, RF
    ARDITTI, A
    AGMON, J
    PINKHAS, J
    ISRAEL JOURNAL OF MEDICAL SCIENCES, 1984, 20 (06): : 535 - 537
  • [10] LIFE-THREATENING ARRHYTHMIAS AND INTRAVENOUS CIMETIDINE
    FRY, ENS
    BRITISH MEDICAL JOURNAL, 1979, 2 (6197): : 1075 - 1075